Jobs / United States / Regeneron Pharmaceuticals INC
Associate Director Finance Transformation
Regeneron Pharmaceuticals INC · 🇺🇸 SLEEPY HOLLOW
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles13 certified filings for “Associate Director Imaging” (Natural Sciences Managers) in NY: $201k–$281k, median $225k. Most were filed at wage level II (69%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
The Associate Director, Finance Transformation, is responsible for driving strategic initiatives that improve the effectiveness, scalability, and operational performance of Finance. This role partners with Finance Operations, Shared Services, IT, and business stakeholders to lead process optimization, technology enablement, standardization, and continuous improvement efforts across the organization. The Associate Director will identify opportunities to simplify and modernize finance processes, enhance service delivery, strengthen controls, and support enterprise transformation initiatives. Success in this role requires a deep understanding of finance operations, strong leadership capabilities, and experience leveraging key Finance technologies including Oracle Fusion, Hyperion, Tableau, BI Publisher, and other enterprise platforms to improve business outcomes. This role is based in our Sleepy Hollow, NY office and is required to be on-site 4 days per week. Key Responsibilities • Finance Operations Leadership: Leads Finance operational excellence initiatives by driving process standardization, performance improvement, scalability, risk reduction, and service delivery enhancements aligned with business priorities. • Process Improvement & Transformation: Oversees Finance process transformation efforts through continuous improvement, automation, and change management to increase efficiency, controls, and scalability. • Technology Enablement: Partners with Finance and IT teams to optimize and implement enterprise technologies, leveraging automation, AI, and analytics platforms to improve business performance and decision support. • Reporting, Analytics & Decision Support: Delivers actionable financial and operational insights through standardized reporting, data governance, performance metrics, and trend analysis to support strategic decision-making. • Stakeholder Management: Builds and manages cross-functional partnerships, driving collaboration, executive communication, and data-driven recommendations to achieve operational and transformation objectives. Qualifications Required Qualifications • Bachelor's degree required in Finance, Accounting, Business Administration, Information Systems, or a related field. MBA preferred. • 10+ years of progressive experience in Finance Operations, Shared Services, Finance Transformation, or related disciplines. • 5+ years of leadership experience managing teams and complex cross-functional initiatives. • Demonstrated experience leading process improvement, operational excellence, and technology-enabled transformation initiatives. • Strong understanding of finance processes, controls, and enterprise operations. Preferred Qualifications • CPA, CMA, PMP, Lean Six Sigma, or equivalent certification. • Experience supporting large-scale Finance Transformation or ERP initiatives. • Knowledge of Oracle Fusion, Hyperion, Tableau, BI Publisher, Power BI, automation platforms, and AI-enabled technologies. • Experience in global organizations and shared services environments. • Proven ability to drive measurable operational improvements and business value. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic